Latest Research in Protein Degradation and Inhibitors
16 research papers · 2026 median publication year
Top Research Topics in Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors — 2 papers
- Immune cells in cancer — 2 papers
- Click Chemistry and Applications — 2 papers
- Cancer Research and Treatments — 1 papers
- DNA and Nucleic Acid Chemistry — 1 papers
- Nanoparticle-Based Drug Delivery — 1 papers
- Ultrasound and Hyperthermia Applications — 1 papers
- Nanoplatforms for cancer theranostics — 1 papers
- RNA Interference and Gene Delivery — 1 papers
- Coagulation, Bradykinin, Polyphosphates, and Angioedema — 1 papers
Highest-Cited Papers
- Engineered probiotics for tumor-targeted combination chemoimmunotherapy
- Versatile H-Phosphonate Platform for Backbone-Modified Dinucleotide Blockmers Enabling Oligonucleotide SAR
- Peptide-mediated nanotheranostics for glioblastoma
- Self‐Assembled Aptamer‐Derived PROTAC Enables Efficient Cellular Internalization for Intracellular Sclerostin Degradation and Triple‐Negative Breast Cancer Therapy
- Antagonistic peptide-displayed artificial exosome carrying PROTAC for the synergistic lung cancer therapy
- Sequential Mannose-Targeted Nanotherapy Orchestrates Tumor-Associated Macrophage Repolarization and Chemotherapeutic Response in Triple-Negative Breast Cancer
- Inhibiting glioma cell invasion by sequential photo-sonodynamic therapy
- Comparative study of mannose-containing polysaccharide nanogels for optimized M2 macrophage targeting and photoacoustic imaging
- Click‐Activated Supramolecular Targeting Chimeras for Spatiotemporally Resolved Protein Degradation In Vivo
- Click‐Activated Supramolecular Targeting Chimeras for Spatiotemporally Resolved Protein Degradation In Vivo
- Reinforcement of Solid Lipid Nanoparticles for Targeted PD-L1 Downregulation in Breast Cancer
- Albumin Nanoparticle–Mediated Codelivery of Regorafenib and Paclitaxel Boosts Chemoimmunotherapy of Peritoneal Metastases
- An engineered pneumolysin ΔA146 derivative induces apoptosis in breast cancer cells: an in vitro proof-of-concept for antibody-drug conjugate payload development
- Pyroptosis‐Amplified Decoy Nanovesicles Orchestrate Pyroptotic Antigen Explosion and Endogenous Immune Revitalization for Potentiating Tumour Immunotherapy
- Engineered nanocomplex for targeted delivery of Beclin1 peptide enables autophagy-mediated tumor suppression and immune activation
- Single‐Dose TACE‐Like Injection of Sustained‐Release Panobinostat/IL‐12 Polymeric Microparticles is Effective in Preclinical Liver Cancer Models